Cargando…

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

BACKGROUND: Immunotherapy, especially immune checkpoint inhibition, has provided powerful tools against cancer. We aimed to detect the expression of common immune checkpoints and evaluate their prognostic values in nasopharyngeal carcinoma (NPC). METHODS: The expression of 9 immune checkpoints consi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ya-Qin, Zhang, Yu, Jiang, Wei, Chen, Yu-Pei, Xu, Shuo-Yu, Liu, Na, Zhao, Yin, Li, Li, Lei, Yuan, Hong, Xiao-Hong, Liang, Ye-Lin, Li, Jun-Yan, Zhang, Lu-Lu, Yun, Jing-Ping, Sun, Ying, Li, Ying-Qin, Ma, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854706/ https://www.ncbi.nlm.nih.gov/pubmed/31722750 http://dx.doi.org/10.1186/s40425-019-0752-4

Ejemplares similares

Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients
por: Wang, Ya-Qin, et al.
Publicado: (2021)

Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology
por: Wang, Ya-Qin, et al.
Publicado: (2020)

Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades
por: Li, Jun-Yan, et al.
Publicado: (2021)

A Five-MicroRNA Signature Predicts the Prognosis in Nasopharyngeal Carcinoma
por: Wu, Shixiong, et al.
Publicado: (2021)

Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma
por: Zhu, Yu-Ting, et al.
Publicado: (2023)

ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3
por: Zhao, Yin, et al.
Publicado: (2020)

Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma
por: Zeng, Liang, et al.
Publicado: (2023)

High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma
por: Xu, Ya-Fei, et al.
Publicado: (2015)

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses
por: Chen, Yu-Pei, et al.
Publicado: (2021)

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
por: Chen, Yu-Pei, et al.
Publicado: (2020)

TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma
por: Ren, Xian-Yue, et al.
Publicado: (2018)

Predicting prognosis of nasopharyngeal carcinoma based on deep learning: peritumoral region should be valued
por: Li, Song, et al.
Publicado: (2023)

Influence of Cervical Node Necrosis of Different Grades on the Prognosis of Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
por: Zhang, Lu-Lu, et al.
Publicado: (2017)

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
por: Zhang, Hongpan, et al.
Publicado: (2022)

Effects of hepatitis B virus infection and antiviral therapy on the clinical prognosis of nasopharyngeal carcinoma
por: Weng, Jing‐Jin, et al.
Publicado: (2019)

Critical weight loss predicts poor prognosis in nasopharyngeal carcinoma
por: Zeng, Qi, et al.
Publicado: (2016)

The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
por: Jia, Xiao-Hui, et al.
Publicado: (2020)

The four-microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients
por: Zhang, Siwei, et al.
Publicado: (2019)

Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China
por: Qiao, Han, et al.
Publicado: (2022)

Clinical and pathological characteristics and prognosis of 132 cases of rectal neuroendocrine tumors
por: Yu, Yong-Jun, et al.
Publicado: (2020)

A Prognostic Score for Nasopharyngeal Carcinoma with Bone Metastasis: Development and Validation from Multicenter
por: Chen, Chen, et al.
Publicado: (2018)

NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription()()
por: Zhang, Jian, et al.
Publicado: (2019)

Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer
por: Zeng, Hao, et al.
Publicado: (2021)

Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma
por: Peng, Ying-peng, et al.
Publicado: (2021)

Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma
por: Zhou, Jinhui, et al.
Publicado: (2022)

Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma
por: Yu, Ying, et al.
Publicado: (2020)

Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)
por: Zhao, Yin, et al.
Publicado: (2020)

Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma
por: Liang, Yelin, et al.
Publicado: (2020)

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
por: Wang, Jia‐Bin, et al.
Publicado: (2023)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer
por: Yu, Jing, et al.
Publicado: (2021)

Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer
por: Liu, Qin, et al.
Publicado: (2021)

Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma
por: Ouyang, Fu-Sheng, et al.
Publicado: (2017)

Development and Validation of a Five-RNA–Based Signature and Identification of Candidate Drugs for Neuroblastoma
por: Zhang, PeiPei, et al.
Publicado: (2021)

The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma
por: Zhou, Ji, et al.
Publicado: (2023)

Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis
por: Zhou, De-Hua, et al.
Publicado: (2022)

Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation
por: Wen, Jia-Ying, et al.
Publicado: (2022)

Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Corrigendum to “NFAT1 hypermethylation promotes epithelial‐mesenchymal transition and metastasis in nasopharyngeal carcinoma by activating ITGA6 transcription” [Neoplasia 21 (2019): 311–321]
por: Zhang, Jian, et al.
Publicado: (2021)

A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma
por: Liang, Ye-Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3l4qj7cqm83r5bkd95sptjv6ts